Audrey Tanksley
Internal Medicine · Evergreen Park, ILNPI 1750524518
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Indivior Inc. accounts for 76.2% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $7,575, more than ten times the $460 reported in 2019. Among internal medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $91.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$7K
- AstraZeneca$434
- Viiv Healthcare Company$417
- GSK$247
- Gilead$232
- Merck$180
- plus $769 from 18 others
What the payments were for
- Speaking & faculty fees$4,19944%
- Travel & lodging$2,02921%
- Food & beverage$3,31835%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 30 | $7,279 |
| AstraZeneca | 10 | $434 |
| Viiv Healthcare Company | 7 | $417 |
| GSK | 9 | $247 |
| Gilead | 7 | $232 |
| Merck | 4 | $180 |
| AbbVie | 9 | $179 |
| Orexo US, Inc. | 5 | $98 |
| Pear Therapeutics (US), Inc. | 1 | $69 |
| Braeburn Inc. | 4 | $67 |
| USWM, LLC | 3 | $55 |
| Pfizer | 2 | $43 |
| Alkermes, Inc. | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Tris Pharma Inc | 1 | $25 |
| Corium, LLC | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Coopersurgical, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,557 in reported general payments places this provider in the 95th percentile of 5,182 internal medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 22 | $3,112 |
| Amlodipine Besylate | 18 | $162 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Evergreen Park
- Joaquim Spadoni BarbozaEvergreen Park$75K
- Zaid JabbarOak Brook$1.2M
- Merle DiamondChicago$1.1M
- David ReckerLibertyville$868K
- Yazen JoudehOrland Park$661K
- Robert KushnerChicago$516K
- William CruikshankOak Lawn$431K
- Romeo UrsuaChicago$420K
- Shaina RozellChicago Ridge$366K
- Kristi Tough DesapriWinnetka$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.